Literature DB >> 9825115

Interference of myrtol standardized with inflammatory and allergic mediators.

N Beuscher1, M Kietzmann, E Bien, P Champeroux.   

Abstract

Myrtol standardized (Gelomyrtol/Gelomyrtol forte) inhibits the activity of 5-lipoxygenase of human basophil and eosinophil leukocytes and the formation of leukotriene C4 as well as 1.8-cineole (eucalyptol). An increase of prostaglandins (PGE2) in mucous membranes of teat cisterns after topical administration of TPA (tetradecanoylphorbol-13-acetate) was inhibited. In vitro and in vivo studies revealed spasmolytic and broncholytic effects of Myrtol stand. After topical administration into the teat cisterns of the isolated bovine udder Myrtol stand. increased the surface temperature, comparable to effects of menthol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9825115

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  Myrtol ameliorates cartilage lesions in an osteoarthritis rat model.

Authors:  Binbin Ying; Abudu Kelimujiang Maimaiti; Donghui Song; Songsong Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Myrtol improves post-traumatic knee osteoarthritis by regulation of reactive oxygen species, transforming growth factor β1 and apoptosis in a mouse model.

Authors:  Liqun Duan; Wenzhi Zhang; Feng Zhang; Haiping Cai
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

3.  1,8-cineol, a food flavoring agent, prevents ethanol-induced gastric injury in rats.

Authors:  F A Santos; V S Rao
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

4.  Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease.

Authors:  U Rantzsch; G Vacca; R Dück; A Gillissen
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

5.  Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Kai-Michael Beeh; Jutta Beier; Henning Candler; Thomas Wittig
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-23

Review 6.  Is Myrtol® Standardized a New Alternative toward Antibiotics?

Authors:  Maria Paparoupa; Adrian Gillissen
Journal:  Pharmacogn Rev       Date:  2016 Jul-Dec

Review 7.  Complementary and integrative treatments: rhinosinusitis.

Authors:  Malcolm B Taw; Chau T Nguyen; Marilene B Wang
Journal:  Otolaryngol Clin North Am       Date:  2013-04-28       Impact factor: 3.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.